Patent ID: 6670361
Filing Date: 2003-12-30
Classification: A61P,C07H

Abstract:
A method for treating cancer excluding adenocarcinoma, and selected from the group consisting of malignant epithelioma, sarcoma, gliomatosis, melanoma, lymphoma and leukemia, comprising administering to a patient in need thereof and suffering from said cancer, a pharmaceutically effective amount of at least one sulfoquinovosylacylglycerol compound represented by formula (1): wherein the bond between the D-glucosyl moiety and the glyceridyl moiety is in the &agr;-configuration, R101 is represented by CH3(CH2)nCOâ€”, wherein n is an integer of 12 to 24, and R102 is a hydrogen atom or CH3(CH2)nCOâ€”, wherein n is an integer of 12 to 24, or a pharmaceutically acceptable salt thereof, alone or in combination with a pharmaceutically acceptable carrier.